Phase II study of the failure of vincristine and bleomycin for previously treated children with metastatic neuroblastoma: a report from the Childrens Cancer Study Group
Bernstein, I.D.; Evans, A.E.; Finklestein, J.; Klemperer, M.; Hittle, R.; Leikin, S.; Hammond, G.D.
Cancer Treatment Reports 62(8): 1201-1202
1978
ISSN/ISBN: 0361-5960 PMID: 80272 Document Number: 137550
Patients [22] with previously treated, but progressive stage IV neuroblastoma, received combination therapy with vincristine (1.0 mg/m2) followed in 6 h by bleomycin (15 mg/m2). Therapy was administered twice weekly. No responses were seen in the 19 patients who received 4 or more doses of the bleomycin-vincristine combination.
Document emailed within 1 workday
Related Documents
Lewis, I.J.; Lashford, L.S.; Fielding, S.; Flower, M.A.; Ackery, D.; Kemshead, J. 1991: A phase I/Ii study of 131i mIBG in chemo-resistant neuroblastoma. the United Kingdom Children's Cancer Study Group (UKCCSG) Progress in Clinical and Biological Research 366: 463-469Van Cutsem, E.; Blijham, G.H. 1999: Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group Seminars in Oncology 26(1 Suppl. 5): 13-20
Baehner, R.L.; Bernstein, I.D.; Sather, H.; Higgins, G.; McCreadie, S.; Chard, R.L.; Hammond, D. 1984: Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group Cancer Treatment Reports 68(10): 1269-1272
Boros, L.; Tsiatis, A.A.; Neiman, R.S.; Mann, R.B.; Glick, J.H. 1986: Phase Ii Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma Cancer Treatment Reports 70(7): 917-918
Nesbit, M.E.; Sather, H.; Robison, L.L.; Donaldson, M.; Littman, P.; Ortega, J.A.; Hammond, G.D. 1982: Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group Cancer Research 42(2): 674-680
Cowan, J.D.; Surwit, E.A.; Alberts, D.S.; Boutselis, J.G.; Neilan, B.A. 1986: Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study Cancer Treatment Reports 70(3): 423-424
Amrein, P.C.; Coleman, M.; Richards, F.; Poulin, R.F.; Bernhardt, B.; Ginsberg, S.J.; Green, M.R.; Morrison, A.; Cortes, E.; Kiang, D.; Weinberg, V.; Wood, W.C. 1982: Phase Ii study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study Cancer Treatment Reports 66(5): 1211-1213
Miller, D.R.; Steinherz, P.G.; Feuer, D.; Sather, H.; Hammond, D. 1983: Unfavorable prognostic significance of hand mirror cells in childhood acute lymphoblastic leukemia. A report from the childrens Cancer Study Group American Journal of Diseases of Children 137(4): 346-350
Carpenter, J.T.; Raney, M.; Logan, T. 1986: Phase Ii evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(5): 679-680
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
Matsukado, Y.; Abe, H.; Tanaka, R.; Kobayashi, T.; Yamashita, J.; Nishimoto, A.; Ushio, Y.; Sato, K.; Matsutani, M.; Takakura, K. 1986: Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a phase II study--The Japanese Intracranial Germ Cell Tumor Study Group Gan No Rinsho. Japan Journal of Cancer Clinics 32(11): 1387-1393
Gridelli, C.; Frontini, L.; Barletta, E.; Rossi, A.; Barzelloni, M.L.; Scognamiglio, F.; Guida, C.; Gatani, T.; Fiore, F.; De Bellis, M.; Marfella, A.; Manzione, L. 2000: Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature Anticancer Research 20(2b): 1077-1084
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
George, R.E.; Kenyon, R.M.; McGuckin, A.G.; Malcolm, A.J.; Pearson, A.D.; Lunec, J. 1996: Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group Oncogene 12(7): 1583-1587
Sievers, E.L.; Smith, F.O.; Woods, W.G.; Lee, J.W.; Bleyer, W.A.; Willman, C.L.; Bernstein, I.D. 1995: Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer Group Leukemia 9(12): 2042-2048
Lehnert, M.; Biffl, G.; Wascher, H.; Jordis-Lohausen, K.; Wählby, S. 1986: A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase Ii study Seminars in Oncology 13(1 Suppl 1: 32-34
Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528
Albright, A.L.; Wisoff, J.H.; Zeltzer, P.M.; Deutsch, M.; Finlay, J.; Hammond, D. 1989: Current neurosurgical treatment of medulloblastomas in children. A report from the Children's Cancer Study Group Pediatric Neuroscience 15(6): 276-282